SCHEMBL20074300

SCHEMBL20074300

CC(C)(C)c1c(Cl)[nH]c2ncnn2c1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.36
MEN1 O00255 1/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.32
CHEK1 O14757 1/20 0.32
AURKA O14965 1/20 0.32
DAPK3 O43293 1/20 0.32
JAK2 O60674 1/20 0.32
MAP4K4 O95819 1/20 0.32
ABL1 P00519 1/20 0.32
NTRK1 P04629 1/20 0.32
LCK P06239 1/20 0.32
CSF1R P07333 1/20 0.32
RET P07949 1/20 0.32
MET P08581 1/20 0.32
PDGFRB P09619 1/20 0.32
PIM1 P11309 1/20 0.32
FGFR1 P11362 1/20 0.32
PDGFRA P16234 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20074103 0.74 KDM5B (0.42) TSHRMEN1KMT2AMAPK14ALDH1A1
SCHEMBL20074104 0.73 KDM5B (0.45) TSHRAURKAACVR1LRRK2AURKB
SCHEMBL20074102 0.72 KDM5B (0.46) TSHR
SCHEMBL21721676 0.68 KDM5B (0.50) TSHRMEN1HPGDKMT2ATDP1
SCHEMBL31677011 0.66 TDP1 (0.40) TSHRMEN1HPGDKMT2ATDP1
SCHEMBL20074183 0.66 TSHR (0.36) TSHRTDP1ALDH1A1SIRT5
SCHEMBL20074188 0.64 TSHR (0.43) TSHRMEN1HPGDKMT2ATDP1
SCHEMBL20074197 0.64 TSHR (0.41) TSHRMEN1HPGDKMT2ATDP1
SCHEMBL20074191 0.63 TSHR (0.38) TSHRHPGDTDP1ALDH1A1SIRT5
SCHEMBL20074187 0.62 ALDH1A1 (0.43) TSHRMEN1HPGDKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3525785-B1 KDM5 INHIBITORS MERCK SHARP & DOHME LLC (US) 2025-08-27 EP claimed
US-10975084-B2 KDM5 inhibitors MERCK SHARP & DOHME CORP. (US) 2021-04-13 US disclosed
US-20200048258-A1 KDM5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2020-02-13 US disclosed
WO-2018071283-A1 KDM5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2018-04-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048258-A1 KDM5 INHIBITORS KDM5A, KDM5B, KDM5C TSHR 4342/4885MEN1 2010/4885HPGD 3907/4885
US-10975084-B2 KDM5 inhibitors KDM5A, KDM5B, KDM5C TSHR 4342/4885MEN1 2010/4885HPGD 3907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.